Coya Therapeutics (COYA)

• Market cap: $110M
• 1 day: -2.08%
• 5 days: -2.69%
• 1 month: 7.05%
• 3 months: -5.42%
• 6 months: -26.18%
• Year to date: -16.64%
• 1 year: -17.22%
• 5 years: 3.06%
• 10 years: 3.06%
• Sector: Healthcare
• Industry: Biotechnology

About: Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.

Employees: 8